Aveo Board Dumps Cancer Drug Derivative Suit
Board members at Aveo Pharmaceuticals Inc. dodged a derivative suit Tuesday when a Massachusetts federal judge ruled that the plaintiff didn't back her claims that the board was liable and should...To view the full article, register now.
Already a subscriber? Click here to view full article